Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating intraocular lens (IOL) for use in the surgical treatment of these conditions.
The device is designed to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
Funding Rounds (1) - $40MUpdate
|Oct 21, 2009||BioSpace - Abbott Laboratories (ABT) Completes Visiogen, Inc. Acquisition|
|Sep 24, 2009||smartmoney.com - Abbott Labs acquired Visiogen|
|Jun 24, 2009||OnBioVC - Visiogen, Inc.: Series D $40MbyOnBioVC|
|Apr 27, 2009||SoCal - Tech - Visiogen Gains $40M In Funding|
2 Goodyear, Suite B
Irvine, CA 92618